Metrovacesa
€10.28Change from previous close: +0.39%Absolute change: +€0.04
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €1.56B
- Enterprise value
- €1.78B
- P/E (trailing 12 months)
- 17.4
- Forward P/E
- 22.8
- Price/book
- 1.20
- Price/sales
- 1.74
- EV/EBITDA
- 10.7
- EV/revenue
- 2.00
Profitability and growth
- Gross margin
- 24.6%
- Operating margin
- 8.1%
- Net margin
- 10.1%
- ROE
- 6.4%
- ROA
- 4.5%
- Revenue growth (year over year)
- 139.5%
Financial health
- Total cash
- €159.82M
- Total debt
- €389.35M
- Debt/equity
- 0.30
- Current ratio
- 3.28
- Quick ratio
- 0.47
Dividends
- Annual dividend per share
- €2.02
- Dividend yield
- 19.7%
- Payout ratio
- 339.6%
- Ex-dividend date
- May 20, 2026
Analysts and estimates
- Average price target
- €11.09
- Median price target
- €11.50
- High price target
- €12.00
- Low price target
- €9.35
- Analysts with a price target
- 4
- Consensus
- Sell
- Forward EPS
- €0.45
- EPS estimate, current year
- €0.44
Shares and trading
- Beta
- 0.68
- Average volume
- 86.4K
- Shares outstanding
- 151.62M
- Float
- 56.57M
- Institutional ownership
- 2.8%
- Insider ownership
- 91.6%